Ticker League

Operating Cash Flow for Abbott Laboratories (ABT)

As of · Reported

Metric

Latest period

$1.31B

YoY change

+11.8%

5Y CAGR

+3.9%

Peak year (2021)

$10.53B

Operating Cash Flow history chart for Abbott Laboratories (ABT) from 1989 to 2025

Latest: $9.57B

Operating Cash Flow growth chart for Abbott Laboratories (ABT) from 1989 to 2025

Latest: +11.8%

Operating Cash Flow history table for Abbott Laboratories (ABT) from 1989 to 2025

  • 2025$9.57B+11.8%
  • 2024$8.56B+17.9%
  • 2023$7.26B-24.2%
  • 2022$9.58B-9.0%
  • 2021$10.53B+33.3%
  • 2020$7.90B+28.8%
  • 2019$6.14B-2.6%
  • 2018$6.30B+13.1%
  • 2017$5.57B+73.9%
  • 2016$3.20B+8.0%
  • 2015$2.97B-19.3%
  • 2014$3.67B+10.6%
  • 2013$3.32B-64.3%
  • 2012$9.31B+3.8%
  • 2011$8.97B+2.7%
  • 2010$8.74B+20.1%
  • 2009$7.28B-0.9%
  • 2008$7.34B+41.7%
  • 2007$5.18B-2.7%
  • 2006$5.33B+3.0%
  • 2005$5.17B+17.4%
  • 2004$4.41B+17.7%
  • 2003$3.75B-10.4%
  • 2002$4.18B+17.3%
  • 2001$3.57B+15.1%
  • 2000$3.10B+5.5%
  • 1999$2.94B+7.5%
  • 1998$2.73B+4.0%
  • 1997$2.63B+10.4%
  • 1996$2.38B+21.2%
  • 1995$1.97B-11.1%
  • 1994$2.21B+19.8%
  • 1993$1.85B+33.0%
  • 1992$1.39B-4.4%
  • 1991$1.45B+21.0%
  • 1990$1.20B+25.1%
  • 1989$959.90M—

Operating Cash Flow values are taken from Abbott Laboratories's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Cash Flow at Abbott Laboratories (ABT)

Operating Cash Flow for Abbott Laboratories (ABT): headline value $1.31B · YoY +11.8%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, Abbott Laboratories (ABT) operating cash flow totalled $9.57B – grew 11.8% year-over-year.

Abbott Laboratories operating cash flow compound annual growth for the 2020–2025 (5 years) window is +3.9%, sustaining 2 straight years of year-over-year growth.

Abbott Laboratories operating cash flow peaked at $10.53B in 2021; the latest annual figure is $9.57B in 2025 (9.2% below peak).

$10.53B stands as the all-time-high annual operating cash flow, posted in 2021, against a low of $959.90M during 1989.

Abbott Laboratories Operating Cash Flow by Year

Abbott Laboratories Operating Cash Flow 2025: $9.57B

Abbott Laboratories posted operating cash flow of $9.57B in 2025, grew 11.8% from 2024.

Abbott Laboratories Operating Cash Flow 2024: $8.56B

In 2024, Abbott Laboratories reported operating cash flow of $8.56B, grew 17.9% from 2023.

Abbott Laboratories Operating Cash Flow 2023: $7.26B

Abbott Laboratories operating cash flow in 2023 was $7.26B, declined 24.2% below 2022.

Abbott Laboratories Operating Cash Flow 2022: $9.58B

2022's operating cash flow for Abbott Laboratories came in at $9.58B, declined 9.0% below 2021.

Abbott Laboratories Operating Cash Flow 2021: $10.53B

Abbott Laboratories operating cash flow in 2021 was $10.53B.

See more financial history for Abbott Laboratories (ABT).

Sector peers by Operating Cash Flow

Healthcare peers of Abbott Laboratories (ABT), ranked by their latest operating cash flow

Frequently asked questions

Abbott Laboratories (ABT) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview